Novel Antipsychotics and Patient Care in State Hospitals

Abstract

State hospital services have, by and large, embraced the developments in pharmacotherapy of schizophrenia. Optimal use of these new agents in this population requires additional information on their relative efficacy in specific patient subgroups.

Hospitalization risks in the treatment of bipolar disorder: comparison of antipsychotic medications

“…Consequently, the risk for serious relapse is likely to be manifested in divergent hospitalization rates among patients, depending on the type of antipsychotic treatment. Several studies have compared the ability of atypical and typical antipsychotics to prevent hospitalization, mainly in schizophrenia (16, 18, 20–22).…”

“…Several past studies, focusing mainly on patients with schizophrenia, have used incidence of hospitalization to evaluate various antipsychotic therapies (14–22). A number of these studies found hospitalization to be lower in patients treated with atypical antipsychotics than in those treated with typical antipsychotics.…”

Hospitalisation risks in the treatment of schizophrenia in a Medicaid population: comparison of antipsychotic medications

“…Several studies have compared the various antipsychotic therapies with respect to risk for hospitalisation (8)(9)(10)(11)(12)(13)(14)(15)(16). The present study investigated the relationship between hospitalisation and antipsychotic treatment within a Medicaid population with schizophrenia.…”